Neuroleptanalgesia in otorhinolaryngology.
NEUROLEPTANALGESIA is described for its use in the management of otolaryngologic cases undergoing elective surgery. 100 cases have been reviewed extensively. The advantages and possible problems are outlined. It seems to be a highly satisfactory alternative to conventional general anesthetic techniques for most ear, nose and throat procedures and operations, where quiescence rather than anesthesia is required. The absence of direct myocardial depression and a marked decrease in operative and post-operative morbidity constitute the principal advantages.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008614:Meperidine / Q000494:pharmacology; D008875:Middle Aged; D009458:Neuroleptanalgesia; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D010424:Pentobarbital / Q000494:pharmacology; D011183:Postoperative Complications; D011398:Promethazine / Q000494:pharmacology; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects
D008614:Meperidine; D011398:Promethazine; D010424:Pentobarbital